This white paper invites you into the evolving world of metabolic well‑being, beginning with the overlooked power of the gut. It reveals how human‑residential bifidobacteria such as B‑3 and BB536 interact with the microbiome to influence key metabolic pathways.
Through clinical findings and emerging insights on metabolites like ILA, it highlights how microbiome‑based strategies may offer a more natural, sustainable path toward long‑term wellness.





